165 related articles for article (PubMed ID: 11274805)
1. The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose.
Chidavaenzi OC; Buckton G; Koosha F
Int J Pharm; 2001 Mar; 216(1-2):43-9. PubMed ID: 11274805
[TBL] [Abstract][Full Text] [Related]
2. The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties.
Corrigan DO; Healy AM; Corrigan OI
Int J Pharm; 2002 Mar; 235(1-2):193-205. PubMed ID: 11879754
[TBL] [Abstract][Full Text] [Related]
3. The apparent plasticizing effect of polyethylene glycol (PEG) on the crystallinity of spray dried lactose/PEG composites.
Mosén K; Bäckström K; Thalberg K; Schaefer T; Axelsson A; Kristensen HG
Eur J Pharm Biopharm; 2006 Oct; 64(2):206-11. PubMed ID: 16846723
[TBL] [Abstract][Full Text] [Related]
4. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2004 Apr; 273(1-2):171-82. PubMed ID: 15010141
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
6. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
[TBL] [Abstract][Full Text] [Related]
7. The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials.
Corrigan DO; Healy AM; Corrigan OI
Int J Pharm; 2003 Aug; 262(1-2):125-37. PubMed ID: 12927394
[TBL] [Abstract][Full Text] [Related]
8. The measurement of the β/α anomer composition within amorphous lactose prepared by spray and freeze drying using a simple (1)H-NMR method.
Jawad R; Elleman C; Vermeer L; Drake AF; Woodhead B; Martin GP; Royall PG
Pharm Res; 2012 Feb; 29(2):511-24. PubMed ID: 21901569
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
[TBL] [Abstract][Full Text] [Related]
10. Effects of ethanol to water ratio in feed solution on the crystallinity of spray-dried lactose.
Harjunen P; Lehto VP; Välisaari J; Lankinen T; Paronen P; Järvinen K
Drug Dev Ind Pharm; 2002 Sep; 28(8):949-55. PubMed ID: 12378964
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
Haque MK; Roos YH
Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
[TBL] [Abstract][Full Text] [Related]
12. Crystallo-co-spray drying as a new approach to manufacturing of drug/excipient agglomerates: Impact of processing on the properties of paracetamol and lactose mixtures.
McDonagh AF; Tajber L
Int J Pharm; 2020 Mar; 577():119051. PubMed ID: 31981704
[TBL] [Abstract][Full Text] [Related]
13. Modification of α-lactose monohydrate as a direct compression excipient using roller compaction.
Abu Fara D; Rashid I; Alkhamis K; Al-Omari M; Chowdhry BZ; Badwan A
Drug Dev Ind Pharm; 2018 Dec; 44(12):2038-2047. PubMed ID: 30095020
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Recrystallization of Amorphous Lactose in Nanocomposites Formed by Spray-Drying.
Hellrup J; Alderborn G; Mahlin D
J Pharm Sci; 2015 Nov; 104(11):3760-3769. PubMed ID: 26182904
[TBL] [Abstract][Full Text] [Related]
15. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
16. Moisture sorption, compressibility and caking of lactose polymorphs.
Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.
Qian F; Tao J; Desikan S; Hussain M; Smith RL
Pharm Res; 2007 Aug; 24(8):1551-60. PubMed ID: 17380258
[TBL] [Abstract][Full Text] [Related]
18. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
19. The influence of thermal history on the physical behavior of poly(ethylene glycol) (PEG).
Baldursdottir S; Tian F; Santacruz BG; Jørgensen AC; Rantanen J
Pharm Dev Technol; 2012; 17(2):195-203. PubMed ID: 21077753
[TBL] [Abstract][Full Text] [Related]
20. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
